| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Retrospective Study |
| Article Title |
Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao Cui, Ke-Cheng Zhang, Bo Cao, Huan Deng, Gui-Bin Liu, Li-Qiang Song, Rui-Yang Zhao, Yi Liu, Lin Chen and Bo Wei |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Basic Research Program of China (973 Program) |
2019YFB1311505 |
| National Natural Science Foundation of China |
81773135 |
| National Natural Science Foundation of China |
82073192 |
|
| Corresponding Author |
Bo Wei, MD, PhD, Chief Doctor, Professor, Staff Physician, Department of General Surgery and Institute of General Surgery, the First Medical Center, Chinese PLA General Hospita, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. 18431143691@163.com |
| Key Words |
Neoadjuvant chemotherapy; Gastric cancer; Laparoscope; Total gastrectomy; Morbidity; Survival |
| Core Tip |
Neoadjuvant chemotherapy (NACT) was defined as chemotherapy before surgery which was currently hotspot of perioperative therapy for advanced gastric cancer. We focus on the short- and long-term outcomes between laparoscopic total gastrectomy (LTG) and open total gastrectomy (OTG) after NACT. In this study, we found that LTG group had longer operation time, less blood loss, shorter first flatus and postoperative days. LTG showed comparable 30-d postoperative morbidity as well as 3-year overall survival and disease-free survival rate with no significant difference in comparison with OTG. Based on our results, we recommended experienced surgeons select LTG for proper patients after NACT. |
| Publish Date |
2022-05-25 08:33 |
| Citation |
Cui H, Zhang KC, Cao B, Deng H, Liu GB, Song LQ, Zhao RY, Liu Y, Chen L, Wei B. Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy. World J Gastrointest Surg 2022; 14(5): 452-469 |
| URL |
https://www.wjgnet.com/1948-9366/full/v14/i5/452.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v14.i5.452 |
